Covered recipient · General Payments record
OSSIANY MONS-FIALLO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$422.83
- Reported across 11 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $201.82 | 9 |
| Education | $112.21 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $152.58 | 3 |
| Acerta Pharma LLC | $52.37 | 2 |
| Merck Sharp & Dohme Corporation | $46.48 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.02 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $22.54 | 1 |
| Stemline Therapeutics Inc. | $16.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $20.66 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104509862 | CMS |
| AstraZeneca Pharmaceuticals LP | $31.71 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104393389 | CMS |
| Lilly USA, LLC | $112.21 | 01/23/2024 | Education | Undisputed | 01/23/2026 | 1135898118 | CMS |
| Lilly USA, LLC | $21.11 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135876642 | CMS |
| Lilly USA, LLC | $19.26 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135852936 | CMS |
| Merck Sharp & Dohme LLC | $20.20 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141910826 | CMS |
| Merck Sharp & Dohme LLC | $26.28 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141571160 | CMS |
| Novartis Pharmaceuticals Corporation | $24.02 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087151232 | CMS |
| PUMA BIOTECHNOLOGY, INC. | $22.54 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113836779 | CMS |
| Stemline Therapeutics Inc. | $16.04 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142969851 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.